The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Karyopharm Therapeutics; Ryvu Therapeutics
Consulting or Advisory Role - Abbvie; Blackbird; Bristol-Myers Squibb; CTI; Geron; Karyopharm Therapeutics; Novartis; Ryvu Therapeutics; Sierra Oncology; Taiho Oncology; Takeda; TG Therapeutics
Research Funding - ALX Oncology; Astex Pharmaceuticals; Incyte; Takeda; TG Therapeutics
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim
Using a standard implementation science framework to improve clinical trial enrollment for a community Tennessee oncology center.
 
Neha M Jain
Research Funding - GE Healthcare (Inst)
 
Philip Edward Lammers
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Merck; Pfizer; Puma Biotechnology; Tempus; Teva
 
Michael R. Savona
No Relationships to Disclose
 
Travis John Osterman
Stock and Other Ownership Interests - Infostratix
Consulting or Advisory Role - AstraZeneca; Biodesix; Cota Healthcare; Cota Healthcare; eHealth; Flagship Biosciences; GenomOncology; MDoutlook; Microsoft; Outcomes Insights
Research Funding - GE Healthcare; IBM; Microsoft
Travel, Accommodations, Expenses - GE Healthcare
 
Salil Goorha
Honoraria - Bristol-Myers Squibb/Celgene; Janssen Oncology
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen Oncology